Rivastigmine, memantine
Sponsors
Novartis
Conditions
Alzheimer's Disease
Phase 4
Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
CompletedNCT00234637
Start: 2003-11-30End: 2005-06-30Updated: 2011-11-17
Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
CompletedNCT00305903
Start: 2006-03-31End: 2007-08-31Target: 150Updated: 2007-12-21